These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 30714423)
1. Animal models of ischemic stroke and their impact on drug discovery. Hermann DM; Popa-Wagner A; Kleinschnitz C; Doeppner TR Expert Opin Drug Discov; 2019 Mar; 14(3):315-326. PubMed ID: 30714423 [TBL] [Abstract][Full Text] [Related]
2. [In vivo exploration of cerebral ischemia: use of neuroprotective agents in animal studies]. Lestage P; Lockhart B; Roger A Therapie; 2002; 57(6):554-63. PubMed ID: 12666263 [TBL] [Abstract][Full Text] [Related]
3. Strategies to improve post-stroke behavioral recovery in aged subjects. Buga AM; Bălşeanu A; Popa-Wagner A; Mogoantă L Rom J Morphol Embryol; 2009; 50(4):559-82. PubMed ID: 19942950 [TBL] [Abstract][Full Text] [Related]
4. Ellagic acid-induced thrombotic focal cerebral ischemic model in rats. Pang X; Li T; Feng L; Zhao J; Zhang X; Liu J J Pharmacol Toxicol Methods; 2014; 69(3):217-22. PubMed ID: 24418625 [TBL] [Abstract][Full Text] [Related]
5. Co-ultramicronized Palmitoylethanolamide/Luteolin in the Treatment of Cerebral Ischemia: from Rodent to Man. Caltagirone C; Cisari C; Schievano C; Di Paola R; Cordaro M; Bruschetta G; Esposito E; Cuzzocrea S; Transl Stroke Res; 2016 Feb; 7(1):54-69. PubMed ID: 26706245 [TBL] [Abstract][Full Text] [Related]
6. Advances in stroke pharmacology. Zhou Z; Lu J; Liu WW; Manaenko A; Hou X; Mei Q; Huang JL; Tang J; Zhang JH; Yao H; Hu Q Pharmacol Ther; 2018 Nov; 191():23-42. PubMed ID: 29807056 [TBL] [Abstract][Full Text] [Related]
7. Animal models of cerebral ischemia for evaluation of drugs. Gupta YK; Briyal S Indian J Physiol Pharmacol; 2004 Oct; 48(4):379-94. PubMed ID: 15907047 [TBL] [Abstract][Full Text] [Related]
9. Effect of angiotensin II type 1 receptor blocker, candesartan, and beta 1 adrenoceptor blocker, atenolol, on brain damage in ischemic stroke. Saad MA; Abbas AM; Boshra V; Elkhateeb M; El Aal IA Acta Physiol Hung; 2010 Jun; 97(2):159-71. PubMed ID: 20511125 [TBL] [Abstract][Full Text] [Related]
10. Targeting endothelin receptors for pharmacotherapy of ischemic stroke: current scenario and future perspectives. Kaundal RK; Deshpande TA; Gulati A; Sharma SS Drug Discov Today; 2012 Jul; 17(13-14):793-804. PubMed ID: 22406696 [TBL] [Abstract][Full Text] [Related]
11. Sustained neurological recovery induced by resveratrol is associated with angioneurogenesis rather than neuroprotection after focal cerebral ischemia. Hermann DM; Zechariah A; Kaltwasser B; Bosche B; Caglayan AB; Kilic E; Doeppner TR Neurobiol Dis; 2015 Nov; 83():16-25. PubMed ID: 26316359 [TBL] [Abstract][Full Text] [Related]
12. DJ-1 based peptide, ND-13, promote functional recovery in mouse model of focal ischemic injury. Molcho L; Ben-Zur T; Barhum Y; Offen D PLoS One; 2018; 13(2):e0192954. PubMed ID: 29489843 [TBL] [Abstract][Full Text] [Related]
13. Systemic Proteasome Inhibition Induces Sustained Post-stroke Neurological Recovery and Neuroprotection via Mechanisms Involving Reversal of Peripheral Immunosuppression and Preservation of Blood-Brain-Barrier Integrity. Doeppner TR; Kaltwasser B; Kuckelkorn U; Henkelein P; Bretschneider E; Kilic E; Hermann DM Mol Neurobiol; 2016 Nov; 53(9):6332-6341. PubMed ID: 26572637 [TBL] [Abstract][Full Text] [Related]
14. Animal models of ischemic stroke and their application in clinical research. Fluri F; Schuhmann MK; Kleinschnitz C Drug Des Devel Ther; 2015; 9():3445-54. PubMed ID: 26170628 [TBL] [Abstract][Full Text] [Related]
15. Rodent models of ischemic stroke: a useful tool for stroke drug development. Durukan A; Strbian D; Tatlisumak T Curr Pharm Des; 2008; 14(4):359-70. PubMed ID: 18289062 [TBL] [Abstract][Full Text] [Related]
16. High-dose estrogen treatment at reperfusion reduces lesion volume and accelerates recovery of sensorimotor function after experimental ischemic stroke. Carpenter RS; Iwuchukwu I; Hinkson CL; Reitz S; Lee W; Kukino A; Zhang A; Pike MM; Ardelt AA Brain Res; 2016 May; 1639():200-13. PubMed ID: 26995494 [TBL] [Abstract][Full Text] [Related]
17. Neuroprotective Effects of MAGL (Monoacylglycerol Lipase) Inhibitors in Experimental Ischemic Stroke. Choi SH; Arai AL; Mou Y; Kang B; Yen CC; Hallenbeck J; Silva AC Stroke; 2018 Mar; 49(3):718-726. PubMed ID: 29440474 [TBL] [Abstract][Full Text] [Related]
18. Effectiveness of PSD95 inhibitors in permanent and transient focal ischemia in the rat. Sun HS; Doucette TA; Liu Y; Fang Y; Teves L; Aarts M; Ryan CL; Bernard PB; Lau A; Forder JP; Salter MW; Wang YT; Tasker RA; Tymianski M Stroke; 2008 Sep; 39(9):2544-53. PubMed ID: 18617669 [TBL] [Abstract][Full Text] [Related]
19. Neuroprotective profile of novel SRC kinase inhibitors in rodent models of cerebral ischemia. Liang S; Pong K; Gonzales C; Chen Y; Ling HP; Mark RJ; Boschelli F; Boschelli DH; Ye F; Barrios Sosa AC; Mansour TS; Frost P; Wood A; Pangalos MN; Zaleska MM J Pharmacol Exp Ther; 2009 Dec; 331(3):827-35. PubMed ID: 19741150 [TBL] [Abstract][Full Text] [Related]